Paul Tudor Jones Repare Therapeutics Inc. Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $212,925 - $308,826	17,034 New	17,034 $251,000
Q2 2022 Aug 15, 2022	SELL	$8.45 - $14.84 $175,903 - $308,924	-20,817 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $236,897 - $455,475	20,817 New	20,817 $296,000
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $297,786 - $511,378	-11,502 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.42 - $39.5 $283,499 - $478,147	-12,105 Reduced 51.28%	11,502 $395,000
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $222,094 - $349,579	-10,306 Reduced 30.39%	23,607 $726,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $1.04 Million - $1.12 Million	33,913 New	33,913 $1.05 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.